---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-007723"
form_type: "8-K"
ticker: "ESLA"
cik: "0001844417"
company_name: "Estrella Immunopharma, Inc."
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T15:13:39.421032+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Estrella Immunopharma authorizes up to $1M share repurchase

## Summary
- Board authorized up to $1 million of common stock repurchases; no binding commitment.
- Timing, amount and method of repurchases to be determined by market conditions.
- CEO and CFO state authorization reflects confidence in Estrella's value and strategic direction.
- Repurchase program covers stock traded on Nasdaq under ticker ESLA.

## SEC filing metadata
- accession: 0001213900-24-007723
- form_type: 8-K
- ticker: ESLA
- cik: 0001844417
- company_name: Estrella Immunopharma, Inc.
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844417/000121390024007723/0001213900-24-007723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844417/000121390024007723/ea192451-8k_estrella.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-007723
- JSON: https://secwatch.observer/filing/0001213900-24-007723.json
- Plain text: https://secwatch.observer/filing/0001213900-24-007723.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.